MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Clinical and Genetic Characteristics of HSP Patients by WES Sequencing Combined with MLPA

YW. Cao, HR. Zheng, ZY. Zhu, L. Yao, WT. Tian, L. Cao (Shanghai, China)

Meeting: 2024 International Congress

Abstract Number: 1508

Keywords: Gait disorders: Etiology and Pathogenesis, Spasticity: Clinical features, Spasticity: Genetics

Category: Spasticity

Objective: We aim to clarify the phenotype and gene spectrum of hereditary spastic paraplegia (HSP) and improve the molecular diagnosis.

Background: Next-generation sequencing-based molecular assessment has benefited the diagnosis of HSP subtypes, meanwhile, the molecular diagnosis of nearly half of HSP patients is still equivocal.

Method: A total of 270 clinically suspected HSP patients were included in this study, and multiple ligation-dependent probe amplification (MLPA) technology was used to screen large rearrangements in HSP patients who were negative for whole exome-sequencing (WES).

Results: A total of 60.0% (162/270) patients had a definite molecular diagnosis by MLPA (11.1%) combined with WES (48.9%). SPG4 was the most common subtype in patients with large rearrangements (73.3%), followed by SPG3A (16.7%), SPG6, SPG7 and SPG11 (3.3%). There were some differences in age of onset, sex ratio, phenotype and imaging characteristics across different subtypes. The three most common comorbid symptoms in complicated HSP were intellectual disability, dysarthria, and cerebellar ataxia. In addition, male predilection in some specific genotypes, notably SPG4, SPG7, SPG10, SPG2, SPG76 and SPG30 was observed, suggesting possible sex-dependent differences in expressivity and penetrance. Interestingly, we found that SPG3A patients with large rearrangements had a significantly delayed onset age (33.60±11.28 years), seemingly inconsistent with the common sense that SPG3A is almost exclusively early-onset. Of note, anticipation was a relatively common finding in SPG4 and SPG3A families with large rearrangements.

Conclusion: Large rearrangements account for a considerable proportion of all HSP, and thus, MLPA screening acts as a beneficial supplement to routine WES. This large cohort study provides a more comprehensive understanding of the clinical and genetic features of HSP.

Diagnostic flowchart and clinical profiles

Diagnostic flowchart and clinical profiles

Clinical and genetic spectrum of HSP

Clinical and genetic spectrum of HSP

References: None.

To cite this abstract in AMA style:

YW. Cao, HR. Zheng, ZY. Zhu, L. Yao, WT. Tian, L. Cao. The Clinical and Genetic Characteristics of HSP Patients by WES Sequencing Combined with MLPA [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/the-clinical-and-genetic-characteristics-of-hsp-patients-by-wes-sequencing-combined-with-mlpa/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-clinical-and-genetic-characteristics-of-hsp-patients-by-wes-sequencing-combined-with-mlpa/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley